These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21482963)

  • 41. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
    Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
    J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents.
    Guo D; Lian J; Liu T; Cox R; Margulies KB; Kowey PR; Yan GX
    Heart Rhythm; 2011 May; 8(5):762-9. PubMed ID: 21184845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
    Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
    Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
    J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
    Wu Y; Song Y; Belardinelli L; Shryock JC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
    Frommeyer G; Krawczyk J; Ellermann C; Bögeholz N; Kochhäuser S; Dechering DG; Fehr M; Eckardt L
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):471-476. PubMed ID: 29314443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study.
    Nakamura H; Kurokawa J; Bai CX; Asada K; Xu J; Oren RV; Zhu ZI; Clancy CE; Isobe M; Furukawa T
    Circulation; 2007 Dec; 116(25):2913-22. PubMed ID: 18056530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A slowly inactivating sodium current contributes to spontaneous diastolic depolarization of atrial myocytes.
    Song Y; Shryock JC; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1254-62. PubMed ID: 19700626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium release near L-type calcium channels promotes beat-to-beat variability in ventricular myocytes from the chronic AV block dog.
    Antoons G; Johnson DM; Dries E; Santiago DJ; Ozdemir S; Lenaerts I; Beekman JD; Houtman MJ; Sipido KR; Vos MA
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):326-34. PubMed ID: 26454162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
    Guérard NC; Traebert M; Suter W; Dumotier BM
    J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiarrhythmic effect of IKr activation in a cellular model of LQT3.
    Diness JG; Hansen RS; Nissen JD; Jespersen T; Grunnet M
    Heart Rhythm; 2009 Jan; 6(1):100-6. PubMed ID: 19121808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone.
    Wu L; Rajamani S; Shryock JC; Li H; Ruskin J; Antzelevitch C; Belardinelli L
    Cardiovasc Res; 2008 Feb; 77(3):481-8. PubMed ID: 18006430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
    Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
    Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diastolic spontaneous calcium release from the sarcoplasmic reticulum increases beat-to-beat variability of repolarization in canine ventricular myocytes after β-adrenergic stimulation.
    Johnson DM; Heijman J; Bode EF; Greensmith DJ; van der Linde H; Abi-Gerges N; Eisner DA; Trafford AW; Volders PG
    Circ Res; 2013 Jan; 112(2):246-56. PubMed ID: 23149594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired Inactivation of L-Type Ca2+ Current as a Potential Mechanism for Variable Arrhythmogenic Liability of HERG K+ Channel Blocking Drugs.
    Kim JG; Sung DJ; Kim HJ; Park SW; Won KJ; Kim B; Shin HC; Kim KS; Leem CH; Zhang YH; Cho H; Bae YM
    PLoS One; 2016; 11(3):e0149198. PubMed ID: 26930604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acceleration-induced action potential prolongation and early afterdepolarizations.
    Burashnikov A; Antzelevitch C
    J Cardiovasc Electrophysiol; 1998 Sep; 9(9):934-48. PubMed ID: 9786074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The novel late Na
    Rajamani S; Liu G; El-Bizri N; Guo D; Li C; Chen XL; Kahlig KM; Mollova N; Elzein E; Zablocki J; Belardinelli L
    Br J Pharmacol; 2016 Nov; 173(21):3088-3098. PubMed ID: 27449698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.